319 related articles for article (PubMed ID: 11500805)
21. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function.
Sánchez Más J; Olivares Sánchez C; Ghanem G; Haycock J; Lozano Teruel JA; García-Borrón JC; Jiménez-Cervantes C
Eur J Biochem; 2002 Dec; 269(24):6133-41. PubMed ID: 12473109
[TBL] [Abstract][Full Text] [Related]
22. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix.
Robinson SJ; Healy E
Oncogene; 2002 Nov; 21(52):8037-46. PubMed ID: 12439754
[TBL] [Abstract][Full Text] [Related]
23. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
24. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
Duffy DL; Box NF; Chen W; Palmer JS; Montgomery GW; James MR; Hayward NK; Martin NG; Sturm RA
Hum Mol Genet; 2004 Feb; 13(4):447-61. PubMed ID: 14709592
[TBL] [Abstract][Full Text] [Related]
25. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
[TBL] [Abstract][Full Text] [Related]
26. Novel MC1R variants in Ligurian melanoma patients and controls.
Pastorino L; Cusano R; Bruno W; Lantieri F; Origone P; Barile M; Gliori S; Shepherd GA; Sturm RA; Bianchi-Scarra G
Hum Mutat; 2004 Jul; 24(1):103. PubMed ID: 15221796
[TBL] [Abstract][Full Text] [Related]
27. Melanocortin 1 receptor variants in an Irish population.
Smith R; Healy E; Siddiqui S; Flanagan N; Steijlen PM; Rosdahl I; Jacques JP; Rogers S; Turner R; Jackson IJ; Birch-Machin MA; Rees JL
J Invest Dermatol; 1998 Jul; 111(1):119-22. PubMed ID: 9665397
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
30. Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Bishop DT; Demenais F; Goldstein AM; Bergman W; Bishop JN; Bressac-de Paillerets B; Chompret A; Ghiorzo P; Gruis N; Hansson J; Harland M; Hayward N; Holland EA; Mann GJ; Mantelli M; Nancarrow D; Platz A; Tucker MA;
J Natl Cancer Inst; 2002 Jun; 94(12):894-903. PubMed ID: 12072543
[TBL] [Abstract][Full Text] [Related]
31. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
[TBL] [Abstract][Full Text] [Related]
32. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
33. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
34. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
Höiom V; Tuominen R; Käller M; Lindén D; Ahmadian A; Månsson-Brahme E; Egyhazi S; Sjöberg K; Lundeberg J; Hansson J
Pigment Cell Melanoma Res; 2009 Apr; 22(2):196-204. PubMed ID: 19077144
[TBL] [Abstract][Full Text] [Related]
35. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
36. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
Debniak T; Scott R; Masojc B; Serrano-Fernández P; Huzarski T; Byrski T; Debniak B; Górski B; Cybulski C; Medrek K; Kurzawski G; van de Wetering T; Maleszka R; Kładny J; Lubinski J
Int J Cancer; 2006 Dec; 119(11):2597-602. PubMed ID: 16988943
[TBL] [Abstract][Full Text] [Related]
37. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
Pellegrini C; Fargnoli MC; Suppa M; Peris K
BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
[TBL] [Abstract][Full Text] [Related]
38. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.
Chaudru V; Lo MT; Lesueur F; Marian C; Mohamdi H; Laud K; Barrois M; Chompret A; Avril MF; Demenais F; Bressac-de Paillerets B
Fam Cancer; 2009; 8(4):371-7. PubMed ID: 19484507
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]